LFM A13
Product Sizes
5 mg
£159.00
SIH-461-5MG
25 mg
£455.00
SIH-461-25MG
About this Product
- SKU:
- SIH-461
- Additional Names:
- 2-Cyano-N-(2,5-dibromophenyl)-3-hydroxy-2-butenamide
- CAS Number:
- 62004-35-7
- CE/IVD:
- Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only.
- Extra Details:
- LFM A13 is a selective inhibitor of Bruton's tyrosine kinase (BTK), a key regulator of B-cell receptor signaling and innate immune responses. In neurodegenerative disease research, BTK has emerged as a target for modulating microglial activation and neuroinflammation. LFM A13 is used to explore the role of BTK in central nervous system immune responses and its potential as a therapeutic target in diseases such as multiple sclerosis and Alzheimer's disease.
- Molecular Weight:
- 360
- Purity:
- ≥97%
- Shipping Conditions:
- Ambient
- Source:
- Synthetic
- Storage Conditions:
- -20[o]C
- Supplier:
- StressMarq Biosciences
- Type:
- Proteins, Peptides, Small Molecules & Other Biomolecules: Inhibitors
- Manufacturer's Data Sheet:https://www.stressmarq.com/products/small-molecules/inhibitor/lfm-a13-sih-461/
